av/cyclo-therapeutics--big.svg

NASDAQ:CYTHW

Cyclo Therapeutics

  • Stock

0.72

USD last updated 21/08 01:59:19

Last Close

0.72

26/03 20:00

Market Cap

39.49M

Beta: -

Volume Today

186.81K

Avg: 2.95K

PE Ratio

−1.53

PFCF: −2.83

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of Alzheimer's disease. In addition...Show More

    Earnings

    Earnings per Share (Estimate*)

    -0.5-0.4-0.3-0.2-0.12022-12-312022-12-302023-03-312023-03-302023-06-302023-06-292023-09-302023-09-29

    Revenue (Estimate*)

    200K400K600K800K1M1.20M1.40M2022-12-312022-12-302023-03-312023-03-302023-06-302023-06-292023-09-302023-09-29

    *Estimate based on analyst consensus